Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

NCT05271240 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

432

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Glioblastoma Multiforme
Glioma, Malignant
GBM
Brain Cancer
Glioblastoma, IDH-wildtype
Glioblastoma Multiforme, Adult

Interventions

DRUG: Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
DRUG: Temozolomide and Radiation Alone

Sponsor

Northwell Health